60% of newborns develop jaundice in the first week of their lives.
It's one of the most common neonatal conditions, and the incidence jumps to 80% for preterm infants.
Globally, an estimated 6 million newborns do not receive treatment for severe jaundice because they lack access to effective phototherapy devices. Annually, jaundice causes approximately 30% of newborn deaths in underdeveloped areas, and many survivors suffer lifelong neurological disability as a result of the condition.
The Bili-Hut™ was featured in the Boston Globe on October 26, 2015.
CEO Donna Brezinski was invited to demonstrate the Bili-Hut™ to Congressman Joe Kennedy III during his visit to MassChallenge with the Alliance for Business Leadership.
Little Sparrows Technologies was one of three pediatric medical device companies awarded $25,000 in seed funding from the Philadelphia Pediatric Medical Device Consortium (PPDC).